Editor’s Biography
Downloaded by UCSF LIB CKM RSCS MGMT on November 28, 2014 | http://pubs.acs.org Publication Date (Web): June 12, 2012 | doi: 10.1021/bk-2012-1102.ot001
Anatole A. Klyosov Anatole A. Klyosov, Ph.D., D.Sc., is Chief Scientist and founder of Galectin Therapeutics, a public company, and a co-inventor of the patented technology based on galectin blockers, which often control angiogenesis, inflammation, and immune response in humans. Previously, Dr. Klyosov was Professor of Biochemistry at Harvard Medical School for eight years, and also Vice President of Research and Development of a biotechnology and polymer engineering public company in the Boston area. Prior to that period, he was Professor and Head of the Carbohydrates Research Laboratory at the Institute of Biochemistry, Russian Academy of Sciences. Dr. Klyosov is Fellow, the World Academy of Art and Science (since 1989), holds over 50 U.S. and international patents, has published more than 250 peer-reviewed scientific articles, written books on enzymes, carbohydrates, polymers, and biotechnology, and edited three books: Enzyme Engineering; Carbohydrates in Drug Design; and Galectins. Dr. Klyosov earned his Ph.D. and D.Sc. degrees in physical chemistry from Moscow University.
© 2012 American Chemical Society In Glycobiology and Drug Design; Klyosov, A.; ACS Symposium Series; American Chemical Society: Washington, DC, 2012.
